The DOI matches its Crossref record.
The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models
Abstract
The U.S. Government has pledged to spend $15 billion in Africa and the Caribbean on AIDS. A central focus of this plan is to provide antiretroviral treatment (ART) to millions. Here, we evaluate whether the plan to rollout ART in Africa is likely to generate an epidemic of drug-resistant strains of HIV. We review what has occurred as a result of high usage of ART in developed countries in terms of changes in risky behavior, and the emergence and transmission of drug-resistant HIV. We also review how mathematical models have been used to predict the evolution of drug-resistant HIV epidemics. We then show how models can be used to predict the likely impact of the ART rollout on the evolution of drug-resistant HIV in Africa. At currently planned levels of treatment coverage, we predict that (over the next decade) in Africa: (i) the impact of ART on reducing HIV transmission (and prevalence) is likely to be undetectable (unless accompanied by substantial changes in behavior), (ii) the transmission rate of drug-resistant HIV will be below the WHO surveillance threshold of 5%, and (ii) the majority of cases of drug-resistant HIV that will occur will be due to acquired (and not transmitted) resistance. For the next decade, large-scale surveillance for detecting transmitted resistance in Africa is unnecessary. Instead, we recommend that patients should be closely monitored for acquired resistance, and sentinel surveillance (in a few urban centers) should be used to monitor transmitted resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Setting and Revising Antibacterial Susceptibility Breakpoints
Turnidge, J., & Paterson, D. L. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-06 · Cited by 578
Eaton, J. W., Johnson, L. F., Salomon, J. A., Bärnighausen, T., Bendavid, E., Bershteyn, A., Bloom, D. E., Cambiano, V., Fraser, C., Hontelez, J. A. C., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001245 · Cited by 395
HIV treatment as prevention and HPTN 052
Cohen, M. S., McCauley, M., & Gamble, T. R. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834f5cf2 · Cited by 301
Bennett, D. E., Myatt, M., Bertagnolio, S., Sutherland, D., & Gilks, C. F. (2008) · Antiviral Therapy · doi:10.1177/135965350801302s04 · Cited by 291
Hamers, R. L., Wallis, C. L., Kityo, C., Siwale, M., Mandaliya, K., Conradie, F., Botes, M. E., Wellington, M., Osibogun, A., Sigaloff, K. C. E., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70149-9 · Cited by 287
Metadata
- Authors
- Blower, S., Bodine, E., Kahn, J., & McFarland, W.
- Venue
- AIDS
- Published
- 2005-01
- Volume
- 19
- Issue
- 1
- Pages
- 1-14
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2078212821
- Cited by
- 161
- References
- 0
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. https://app.cochat.ai/papers/10.1097/00002030-200501030-00001
- The paper
- Blower, S., Bodine, E., Kahn, J., & McFarland, W. (2005). The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS. https://doi.org/10.1097/00002030-200501030-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.